Ascendis Pharma A/S Other Current Liabilities
Ascendis Pharma A/S (ASND) had Other Current Liabilities of EUR 58.20 million as of 2025-12-31, per its 20-F filed 2026-02-11.
Financial Statements › Notes
ifrs-full:OtherCurrentLiabilities · last filed 2026-02-11
- 2025-12-31: Other Current Liabilities 58.20M EUR.
- 2025-09-30: Other Current Liabilities 48.30M EUR.
- 2025-06-30: Other Current Liabilities 39.92M EUR.
- 2025-03-31: Other Current Liabilities 38.06M EUR.
| Period end | Other Current Liabilities |
|---|---|
| 2025-12-31 | 58.20M EUR 20-F · filed 2026-02-11 |
| 2025-09-30 | 48.30M EUR 6-K · filed 2025-11-12 |
| 2025-06-30 | 39.92M EUR 6-K · filed 2025-08-07 |
| 2025-03-31 | 38.06M EUR 6-K · filed 2025-05-01 |
| 2024-12-31 | 67.96M EUR 20-F · filed 2026-02-11 |
| 2024-09-30 | 42.24M EUR 6-K · filed 2024-11-14 |
| 2024-06-30 | 26.41M EUR 6-K · filed 2024-09-03 |
| 2024-03-31 | 22.70M EUR 6-K · filed 2024-05-02 |
| 2023-12-31 | 41.18M EUR 20-F · filed 2025-02-12 |
| 2023-09-30 | 33.66M EUR 6-K · filed 2023-11-07 |
| 2023-06-30 | 22.86M EUR 6-K · filed 2023-09-05 |
| 2023-03-31 | 15.50M EUR 6-K · filed 2023-04-27 |
| 2023-01-01 | 31.99M EUR 20-F · filed 2025-02-12 |
| 2022-12-31 | 31.99M EUR 20-F · filed 2024-02-07 |
| 2022-09-30 | 26.58M EUR 6-K · filed 2022-11-02 |
| 2022-06-30 | 20.96M EUR 6-K · filed 2022-08-10 |
| 2022-03-31 | 12.54M EUR 6-K · filed 2022-05-11 |
| 2021-12-31 | 29.95M EUR 20-F · filed 2023-02-16 |
| 2020-12-31 | 23.38M EUR 20-F · filed 2022-03-02 |
| 2019-12-31 | 13.35M EUR 20-F · filed 2021-03-10 |